-
PRME Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Prime Medicine (PRME)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm | 132.04 mm |
Cash burn (monthly) | (no burn) | 169.50 k | 18.08 mm | 18.51 mm | (no burn) | 12.43 mm |
Cash used (since last report) | n/a | 472.29 k | 50.37 mm | 51.57 mm | n/a | 34.64 mm |
Cash remaining | n/a | 131.57 mm | 81.67 mm | 80.47 mm | n/a | 97.40 mm |
Runway (months of cash) | n/a | 776.2 | 4.5 | 4.3 | n/a | 7.8 |
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 29 |
Closed positions | 58 |
Increased positions | 20 |
Reduced positions | 12 |
13F shares | Current |
---|---|
Total value | 118.46 bn |
Total shares | 59.19 mm |
Total puts | 51.30 k |
Total calls | 127.00 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
GV 2019 | 13.28 mm | $0.00 |
ARCH Venture Fund X | 12.26 mm | $0.00 |
ARK Investment Management | 6.13 mm | $31.49 bn |
Newpath Partners | 5.31 mm | $0.00 |
T. Rowe Price Investment Management | 3.73 mm | $19.15 mm |
CMTDF Sumitomo Mitsui Trust | 3.24 mm | $16.65 bn |
Redmile | 2.07 mm | $10.66 bn |
T. Rowe Price | 1.55 mm | $7.95 mm |
Millennium Management | 1.33 mm | $6.84 bn |
STT State Street | 1.10 mm | $5.67 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Dec 24 | Gottesdiener Keith Michael | Stock Option Common Stock | Grant | Acquire A | No | No | 8.32 | 100,000 | 832.00 k | 200,000 |
5 Dec 24 | Richard Brudnick | Stock Option Common Stock | Grant | Acquire A | No | No | 7.96 | 19,300 | 153.63 k | 57,900 |
5 Dec 24 | Allan Reine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 75,000 | 510.00 k | 775,000 |
8 Oct 24 | Gottesdiener Keith Michael | Common Stock | Gift | Acquire G | Yes | No | 0 | 226,925 | 0.00 | 682,259 |
8 Oct 24 | Gottesdiener Keith Michael | Common Stock | Gift | Dispose G | Yes | No | 0 | 226,925 | 0.00 | 50,241 |
12 Jun 24 | Wendy Chung | Stock Option Common Stock | Grant | Acquire A | No | No | 7.68 | 45,000 | 345.60 k | 45,000 |